121 related articles for article (PubMed ID: 8695092)
1. Comparison of neuromuscular, cardiovascular, and histamine-releasing properties of doxacurium and pipecuronium.
Denman WT; Goudsouzian NG; Gelb C
J Clin Anesth; 1996 Mar; 8(2):113-8. PubMed ID: 8695092
[TBL] [Abstract][Full Text] [Related]
2. Clinical pharmacology of doxacurium chloride. A new long-acting nondepolarizing muscle relaxant.
Basta SJ; Savarese JJ; Ali HH; Embree PB; Schwartz AF; Rudd GD; Wastila WB
Anesthesiology; 1988 Oct; 69(4):478-86. PubMed ID: 2972233
[TBL] [Abstract][Full Text] [Related]
3. Train-of-four recovery after pharmacologic antagonism of pancuronium-, pipecuronium-, and doxacurium-induced neuromuscular block in anaesthetized humans.
Stinson LW; Lanier WL; Lennon RL
Acta Anaesthesiol Scand; 1995 Apr; 39(3):406-10. PubMed ID: 7793225
[TBL] [Abstract][Full Text] [Related]
4. Clinical pharmacology of pipecuronium bromide.
Larijani GE; Bartkowski RR; Azad SS; Seltzer JL; Weinberger MJ; Beach CA; Goldberg ME
Anesth Analg; 1989 Jun; 68(6):734-9. PubMed ID: 2544118
[TBL] [Abstract][Full Text] [Related]
5. Newer neuromuscular blocking drugs. An overview of their clinical pharmacology and therapeutic use.
Mirakhur RK
Drugs; 1992 Aug; 44(2):182-99. PubMed ID: 1382013
[TBL] [Abstract][Full Text] [Related]
6. Comparison of hemodynamic responses to pipecuronium and doxacurium in patients undergoing valvular surgery while anesthetized with fentanyl.
Simons LB; Wyble SS; Hirsch LJ; Rooney MW
J Cardiothorac Vasc Anesth; 1994 Jun; 8(3):297-301. PubMed ID: 8061263
[TBL] [Abstract][Full Text] [Related]
7. Hemodynamic and pharmacodynamic comparison of doxacurium and pipecuronium with pancuronium during induction of cardiac anesthesia: does the benefit justify the cost?
Rathmell JP; Brooker RF; Prielipp RC; Butterworth JF; Gravlee GP
Anesth Analg; 1993 Mar; 76(3):513-9. PubMed ID: 8383933
[TBL] [Abstract][Full Text] [Related]
8. Long-acting nondepolarizing neuromuscular blocking agents.
Embree PB
AANA J; 1993 Aug; 61(4):382-7. PubMed ID: 8397465
[TBL] [Abstract][Full Text] [Related]
9. [Histamine plasma concentration and cardiovascular effects of non-depolarizing muscle relaxants: comparison of atracurium, vecuronium, pancuronium and pipecuronium in coronary surgical patients at risk].
Brinkmann M; Günnicker M; Freund U; Schieffer M; Peters J
Anasthesiol Intensivmed Notfallmed Schmerzther; 1998 Jun; 33(6):362-6. PubMed ID: 9689393
[TBL] [Abstract][Full Text] [Related]
10. The cardiovascular effects and histamine-releasing properties of 51W89 in patients receiving nitrous oxide/opioid/barbiturate anesthesia.
Lien CA; Belmont MR; Abalos A; Eppich L; Quessy S; Abou-Donia MM; Savarese JJ
Anesthesiology; 1995 May; 82(5):1131-8. PubMed ID: 7537945
[TBL] [Abstract][Full Text] [Related]
11. Neuromuscular and cardiovascular effects of doxacurium in children anaesthetized with halothane.
Goudsouzian NG; Alifimoff JK; Liu LM; Foster V; McNulty B; Savarese JJ
Br J Anaesth; 1989 Mar; 62(3):263-8. PubMed ID: 2522789
[TBL] [Abstract][Full Text] [Related]
12. The neuromuscular blocking and cardiovascular effects of doxacurium chloride in patients receiving nitrous oxide narcotic anesthesia.
Murray DJ; Mehta MP; Choi WW; Forbes RB; Sokoll MD; Gergis SD; Rudd GD; Abou-Donia MM
Anesthesiology; 1988 Oct; 69(4):472-7. PubMed ID: 3177909
[TBL] [Abstract][Full Text] [Related]
13. Double-blind, randomized, multicenter study of doxacurium vs. pancuronium in intensive care unit patients who require neuromuscular-blocking agents.
Murray MJ; Coursin DB; Scuderi PE; Kamath G; Prough DS; Howard DM; Abou-Donia MA
Crit Care Med; 1995 Mar; 23(3):450-8. PubMed ID: 7874894
[TBL] [Abstract][Full Text] [Related]
14. Pipecuronium revisited: dose-response and maintenance requirement in infants, children, and adults.
Meretoja OA; Erkola O
J Clin Anesth; 1997 Mar; 9(2):125-9. PubMed ID: 9075037
[TBL] [Abstract][Full Text] [Related]
15. Reversal of doxacurium and pancuronium neuromuscular blockade with neostigmine in children.
Bevan JC; Purday JP; Reimer EJ; Bevan DR
Can J Anaesth; 1994 Nov; 41(11):1074-80. PubMed ID: 7828255
[TBL] [Abstract][Full Text] [Related]
16. Clinical pharmacology of doxacurium chloride (BW A938U) in children.
Sarner JB; Brandom BW; Cook DR; Dong ML; Horn MC; Woelfel SK; Davis PJ; Rudd GD; Foster VJ; McNulty BF
Anesth Analg; 1988 Apr; 67(4):303-6. PubMed ID: 2965532
[TBL] [Abstract][Full Text] [Related]
17. Dose-response relations of doxacurium and its reversal with neostigmine in young adults and healthy elderly patients.
Koscielniak-Nielsen ZJ; Law-Min JC; Donati F; Bevan DR; Clement P; Wise R
Anesth Analg; 1992 Jun; 74(6):845-50. PubMed ID: 1534472
[TBL] [Abstract][Full Text] [Related]
18. Neuromuscular block with doxacurium (BW A938U) in patients with normal or absent renal function.
Cashman JN; Luke JJ; Jones RM
Br J Anaesth; 1990 Feb; 64(2):186-92. PubMed ID: 2138489
[TBL] [Abstract][Full Text] [Related]
19. Dose response, recovery, and cost of doxacurium as a continuous infusion in neurosurgical intensive care unit patients.
Prielipp RC; Robinson JC; Wilson JA; MacGregor DA; Scuderi PE
Crit Care Med; 1997 Jul; 25(7):1236-41. PubMed ID: 9233753
[TBL] [Abstract][Full Text] [Related]
20. Clinical evaluation of different doses of pipecuronium bromide during nitrous-oxide-fentanyl anaesthesia in adult surgical patients.
Sanfilippo M; Fierro G; Vilardi V; Rosa G; De Gregorio AL; Gasparetto A
Eur J Anaesthesiol; 1992 Jan; 9(1):49-53. PubMed ID: 1310464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
